Drug Profile
Oxybutynin chloride - ALZA
Alternative Names: Ditropan XL; Lyrinel XL; oxybutynin; Oxybutynin - ALZALatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator ALZA Corporation
- Developer ALZA Corporation; Aventis Pharmaceuticals; Bayer; Crescendo Pharmaceuticals; Sanofi
- Class Alkynes; Antispasmodics; Carbocyclic acids; Cyclohexanes; Diethylamines; Esters; Mandelic acids; Skin disorder therapies; Small molecules
- Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Overactive bladder